Jean Duvall
Fortune : 290 761 $ au 31/05/2026
Fortune : 290 761 $ au 31/05/2026
Jean Marie Duvall is the founder of ReproNovo SA, founded in 2021, serving as Chief Executive Officer & Director.
Ms. Duvall was the founder of Trizell Holding SA, founded in 2014, serving as Director & Chairman-Cell & Gene Therapy.
Ms. Duvall was the founder of Amzell BV, founded in 2016, serving as Director.
Ms. Duvall is also the founder of Cell & Gene Therapy..
Ms. Duvall is a Senior Independent Non-Executive Director at Ondine Biomedical, Inc. since 2021.
Ms. Duvall is Director, Executive VP & Group General Counsel at Ferring International Center SA since 2006.
Ms. Duvall is a Non-Executive Director at Coiled Therapeutics Plc since 2022.
Former positions include Co-Chairman at FerGene, Inc., Director & Executive Vice President at Ferring Pharmaceuticals, Inc., Director at CPSI Holdings Ltd., Director at Ferring Research Ltd., Director at Ferring Laboratories Ltd., Director at Ferring Ventures Ltd., Director at CPSI Scotland Ltd., Director at FinVector Oy, Director at Kuopio Center For Gene & Cell Therapy Kct oy, Director at Gliotherapy Ltd., Director at International School of Lausanne, Director at Ferring Properties SA, Director at Ferring Pharmaceuticals SA from 2006 to 2020, and General Counsel at Elan Corp.
Plc from 2003 to 2005.
Education includes undergraduate studies at Case Western Reserve University and graduate studies at The Ohio State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/04/2026 | 1 438 058 ( 0,28% ) | 290 761 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ONDINE BIOMEDICAL INC. | Directeur/Membre du Conseil | 07/12/2021 |
| ROQT THER | Directeur/Membre du Conseil | 05/04/2022 |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Directeur/Membre du Conseil | - |
Repronovo SA
Repronovo SA BiotechnologyHealth Technology Develops treatments for reproductive medicine and women’s health | Fondateur | 01/01/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Trizell Holding SA | Fondateur | 01/12/2020 |
Amzell BV | Fondateur | 01/01/2020 |
Ferring Pharmaceuticals SA
Ferring Pharmaceuticals SA BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Directeur/Membre du Conseil | 01/01/2020 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Conseiller Juridique Général | 01/01/2005 |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 22 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Ondine Biomedical, Inc.
Ondine Biomedical, Inc. BiotechnologyHealth Technology Engages in the development of non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Health Technology |
CPSI Holdings Ltd. | |
Ferring Research Ltd. | |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops. manufactures and markets pharmaceutical products | Health Technology |
Ferring Pharmaceuticals SA
Ferring Pharmaceuticals SA BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CPSI Scotland Ltd.
CPSI Scotland Ltd. Financial ConglomeratesFinance Provides financial services | Finance |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which provides research and development services | Health Technology |
Kuopio Center For Gene & Cell Therapy Kct oy
Kuopio Center For Gene & Cell Therapy Kct oy Miscellaneous Commercial ServicesCommercial Services Operates as a world-renowned research company | Commercial Services |
Trizell Holding SA | |
Repronovo SA
Repronovo SA BiotechnologyHealth Technology Develops treatments for reproductive medicine and women’s health | Health Technology |
Amzell BV | |
Gliotherapy Ltd. | |
International School of Lausanne | |
Ferring Properties SA |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national